NIH awards Locus Biosciences $3.3M for Phase 1b trial of AI-designed bacteriophage therapy against antibiotic-resistant Pseudomonas aeruginosa hospital-acquired pneumonia.
The human brain runs on 20 watts. A supercomputer that matches its processing capacity needs at least 10 megawatts — six orders of magnitude of energy difference. That gap is not an engineering inconvenience. It is a physical argument that the dominant computing model of the last fifty years may not
EdgeCortix SAKURA-II's USAF flight test and NASA radiation validation prove on-orbit AI inference is production-ready. The convergence of radiation-hardened edge silicon and falling launch costs is turning orbital compute from a research concept into an investable infrastructure layer.
Xellar Biosystems raised $50M in Series A financing for its AI-powered organ-on-chip drug discovery platform — a closed-loop system that bridges biological experiments with computational modeling.
Security robots are entering prime time. Knightscope's K7 begins production in H2 2026. A $20B market is shifting from human guards to autonomous patrols. Three trends — labor crisis, falling sensor costs, and FAA BVLOS rules — make it economically viable.
Security robots are crossing from corporate experiment to infrastructure asset class. Three forces are converging: a 200,000-person guard shortage, AI that works outdoors, and PE hunting for yield in autonomous patrol platforms.
Aurelius Systems opened a US production line for fiber laser modules that power both industrial cutting and directed-energy weapons, closing a supply gap as Pentagon spending surges.
Autonomous debris removal is transitioning from government-funded demonstrations to commercial services. Astroscale's ELSA-M and ESA's ClearSpace-1 both pass critical milestones in 2026, while swarm robotics research opens the path to scalable multi-object capture.